Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 2, 2016, Pages 271-279

  Paoletti, Ernesto ^a   De Nicola, Luca ^b   Gabbai, Francis B ^c   Chiodini, Paolo ^b   Ravera, Maura ^a   Pieracci, Laura ^a   Marre, Sonia ^a   Cassottana, Paolo ^a   Lucà, Sergio ^d   Vettoretti, Simone ^e   Borrelli, Silvio ^b   Conte, Giuseppe ^b   Minutolo, Roberto ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Internal Medicine Santa Maria del Popolo degli Incurabili Hospital   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Blood pressure monitoring, ambulatory; Chronic kidney disease; Echocardiography; Female; Follow up studies; Humans; Hypertension; Hypertrophy, left ventricular; Left ventricular geometry

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; END STAGE RENAL DISEASE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RELATIVE WALL THICKNESS; SENSITIVITY ANALYSIS; AGED; BLOOD PRESSURE MONITORING; CHI SQUARE DISTRIBUTION; DIAGNOSTIC IMAGING; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEART VENTRICLE REMODELING; HYPERTROPHY, LEFT VENTRICULAR; ITALY; KIDNEY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ITALY; KIDNEY; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VENTRICULAR REMODELING;

EID: 84957062658     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06980615     Document Type: Article

References (41)

1. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G: Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 46: 320-327, 2005.
2. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, Strippoli M, Casino F, Giannattasio M, Petrarulo F, Virgilio M, Laraia E, Di Iorio BR, Savica V, Conte G; TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group: Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention. Kidney Int 69:538-545, 2006.
3. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354,1996.
4. Park M, Hsu CY, Li Y, Mishra RK, KeaneM, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23: 1725-1734, 2012.
5. Cai QZ, Lu XZ, Lu Y, Wang AY: Longitudinal changes of cardiac structure and function in CKD (CASCADE study). J Am Soc Nephrol 25: 1599-1608, 2014.
6. Peterson GE, de Backer T, Contreras G, Wang X, Kendrick C, Greene T, Appel LJ, Randall OS, Lea J, Smogorzewski M, Vagaonescu T, Phillips RA; African American Study of Kidney Disease Investigators: Relationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease. Hypertension 62: 518-525, 2013.
7. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA,Wenger NK, WilsonPW, Wright JT Jr.: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn?Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32: 853-906, 1998.
8. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease:Comparison of traditional and novel risk factors. JAMA 293: 1737-1745, 2005.
9. Paoletti E, Bellino D, Gallina AM, Amidone M, Cassottana P, CannellaG: Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease? Nephrol Dial Transplant 26: 670-677, 2011.
10. Chen SC, Su HM, Hung CC, Chang JM, Liu WC, Tsai JC, Lin MY, Hwang SJ, Chen HC: Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 6: 2750-2758, 2011.
11. Chen SC, Chang JM, LiuWC, Huang JC, Tsai JC, Lin MY, Su HM, Hwang SJ, Chen HC: Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Nephrol Dial Transplant 27: 1064-1070, 2012.
12. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19: 1550-1558, 1992.
13. Krumholz HM, Larson M, Levy D: Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 25: 879-884, 1995.
14. Lieb W, Gona P, Larson MG, Aragam J, Zile MR, Cheng S, Benjamin EJ, Vasan RS: The natural history of left ventricular geometry in the community: Clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging 7: 870-878, 2014.
15. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlöf B, Devereux RB: Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 9: 809-815, 2008.
16. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, RizzoniD, Castellano M, Agabiti-Rosei E: Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43:731-738, 2004.
17. Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F, Zaug MF, Burger HU, Drueke TB: Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol 20: 2651-2660,2009.
18. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboli P, Conte G, Gabbai FB, De Nicola L: Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 171: 1090-1098, 2011.
19. Minutolo R, Gabbai FB, Agarwal R, Chiodini P, Borrelli S, Bellizzi V, Nappi F, Stanzione G, ConteG,DeNicola L:Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: A multicenter prospective cohort study. Am J Kidney Dis 64: 744-752, 2014.
20. Agarwal R, Andersen MJ: Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 69: 1175-1180, 2006.
21. Gabbai FB, RahmanM, Hu B, Appel LJ, Charleston J, Contreras G, FaulknerML,Hiremath L, Jamerson KA, Lea JP, LipkowitzMS, Pogue VA, RostandSG, SmogorzewskiMJ,Wright JT,GreeneT,GassmanJ, Wang X, Phillips RA; African American Study of Kidney Disease and Hypertension (AASK) Study Group: Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol 7: 1770-1776, 2012.
22. TaalMW, Brenner BM: Renal risk scores: Progress and prospects. Kidney Int 73: 1216-1219, 2008.
23. Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D: Medical costs of CKD in the Medicare population. J Am Soc Nephrol 24: 1478-1483, 2013.
24. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring: European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31: 1731-1768, 2013.
25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463, 2005.
26. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G, Porcellati C: Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 25: 871-878, 1995.
27. de Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, Girfoglio D, Iovino GL, Trimarco B, De Luca N: Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 56: 99-104, 2010.
28. Colucci WS, Braunwald E: Pathophysiology of heart failure. In: Heart Disease. A Textbook of Cardiovascular Medicine, 6th Ed., edited by Braunwald E, Zipes DP, Libby P, Philadelphia, WB Saunders Company, 2001, pp 503-533.
29. Ricardo AC, Lash JP, Fischer MJ, Lora CM, Budoff M, Keane MG, Kusek JW, Martinez M, Nessel L, Stamos T, Ojo A, Rahman M, Soliman EZ, Yang W, Feldman HI, Go AS; CRIC and HCRIC Investigators: Cardiovascular disease among hispanics and nonhispanics in the chronic renal insufficiency cohort (CRIC) study. Clin J Am Soc Nephrol 6: 2121-2131, 2011.
30. Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Devereux RB: Differences in left ventricular structure between black and white hypertensive adults: The Hypertension Genetic Epidemiology Network study. Hypertension 43: 1182-1188,2004.
31. DraznerMH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, Willett D, Victor RG: Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: The Dallas Heart Study. Hypertension 46: 124-129, 2005.
32. Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, Devereux RB: Gender differences in left ventricular structure and function during antihypertensive treatment: The Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 51: 1109-1114, 2008.
33. Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin Exp Nephrol 17: 730-742, 2013.
34. Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S: Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 90: 928-936, 1994.
35. De Simone G, Devereux RB, Chinali M, Roman MJ, Barac A, Panza JA, Lee ET, Howard BV: Sex differences in obesity-related changes in left ventricular morphology: The Strong Heart Study. J Hypertens 29: 1431-1438, 2011.
36. Wang C, Gong WY, Zhang J, Peng H, Tang H, Liu X, Ye ZC, Lou T: Disparate assessment of clinic blood pressure and ambulatory blood pressure in differently aged patients with chronic kidney disease. Int J Cardiol 183: 54-62, 2015.
37. Tucker B, Fabbian F,GilesM, ThuraisinghamRC, Raine AE, Baker LR: Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 12:724-728, 1997.
38. Cuspidi C, Giudici V, Negri F, Sala C: Nocturnal nondipping and left ventricular hypertrophy in hypertension: An updated review. Expert Rev Cardiovasc Ther 8: 781-792, 2010.
39. Cuspidi C, Facchetti R, Bombelli M, Sala C, Negri F, Grassi G, Mancia G: Nighttime blood pressure and new-onset left ventricular hypertrophy: Findings from the Pamela population. Hypertension 62: 78-84, 2013.
40. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV Jr., Schold JD, Rahman M, Dweik RA: Presence and outcomes of kidney disease in patientswith pulmonary hypertension. Clin J Am Soc Nephrol 9: 855-863, 2014.
41. Bolignano D, Lennartz S, Leonardis D, D'Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C: High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease. Kidney Int 88: 130-136, 2015.